PHAT — PHATHOM PHARMACEUTICALS INC · 全部持有基金
持有基金数（最新）: 39 · 申报持仓市值: $307.37M
| 基金 | 季度 | 股数 | 市值 | 组合权重 | 变动 |
|---|---|---|---|---|---|
| Vanguard Group 历史持仓 | Q4 2025 | 3.18M | $52.71M | 0.00% | 减持 |
| BlackRock Inc 历史持仓 | Q2 2026 | 4.53M | $49.10M | 0.00% | 增持 |
| Invesco Ltd 历史持仓 | Q2 2026 | 4.03M | $43.72M | 0.00% | 减持 |
| Millennium Management 历史持仓 | Q2 2026 | 3.38M | $36.63M | 0.01% | 减持 |
| Franklin Resources 历史持仓 | Q2 2026 | 1.97M | $21.38M | 0.01% | 增持 |
| Goldman Sachs Group 历史持仓 | Q2 2026 | 1.78M | $19.29M | 0.01% | 增持 |
| Geode Capital Management 历史持仓 | Q2 2026 | 1.32M | $14.28M | 0.00% | 减持 |
| Point72 Asset Management 历史持仓 | Q2 2026 | 1.02M | $11.09M | 0.04% | 新建 |
| Moore Capital Management 历史持仓 | Q4 2025 | 600.00K | $9.95M | 0.14% | 持有 |
| Marshall Wace 历史持仓 | Q2 2026 | 666.09K | $7.23M | 0.01% | 减持 |
| Two Sigma Investments 历史持仓 | Q2 2026 | 519.08K | $5.63M | 0.00% | 增持 |
| Northern Trust Corp 历史持仓 | Q2 2026 | 458.30K | $4.97M | 0.00% | 增持 |
| Charles Schwab Investment Management 历史持仓 | Q2 2026 | 419.09K | $4.55M | 0.00% | 增持 |
| Prudential Financial 历史持仓 | Q1 2025 | 568.63K | $3.57M | 0.01% | 增持 |
| JPMorgan Chase & Co 历史持仓 | Q2 2026 | 275.25K | $2.99M | 0.00% | 新建 |
| Renaissance Technologies 历史持仓 | Q2 2026 | 226.40K | $2.46M | 0.00% | 减持 |
| UBS Group AG 历史持仓 | Q2 2026 | 204.57K | $2.22M | 0.00% | 减持 |
| Morgan Stanley 历史持仓 | Q2 2026 | 199.91K | $2.17M | 0.00% | 增持 |
| BNY Mellon 历史持仓 | Q2 2026 | 152.31K | $1.65M | 0.00% | 增持 |
| Wells Fargo & Co 历史持仓 | Q2 2026 | 152.00K | $1.65M | 0.00% | 增持 |
| Bank of America Corp 历史持仓 | Q2 2026 | 151.01K | $1.64M | 0.00% | 减持 |
| AQR Capital Management 历史持仓 | Q2 2026 | 134.90K | $1.46M | 0.00% | 增持 |
| Wellington Management Group 历史持仓 | Q2 2026 | 132.28K | $1.44M | 0.00% | 增持 |
| Balyasny Asset Management 历史持仓 | Q1 2026 | 95.30K | $1.06M | 0.00% | 减持 |
| D. E. Shaw & Co 历史持仓 | Q2 2026 | 95.66K | $1.04M | 0.00% | 减持 |
| Arrowstreet Capital 历史持仓 | Q2 2026 | 77.32K | $838.88K | 0.00% | 新建 |
| Citigroup Inc 历史持仓 | Q2 2026 | 52.95K | $574.45K | 0.00% | 增持 |
| Deutsche Bank AG 历史持仓 | Q2 2026 | 50.20K | $544.73K | 0.00% | 增持 |
| Legal & General Investment Management America 历史持仓 | Q2 2026 | 32.74K | $355.21K | 0.00% | 增持 |
| Citadel Advisors 历史持仓 | Q2 2026 | 31.10K | $337.44K | 0.00% | 减持 |
| Janus Henderson Group 历史持仓 | Q1 2026 | 21.50K | $239.40K | 0.00% | 持有 |
| Lazard Asset Management 历史持仓 | Q2 2026 | 14.67K | $159.18K | 0.00% | 持有 |
| Manulife Financial 历史持仓 | Q2 2026 | 13.63K | $147.90K | 0.00% | 增持 |
| Principal Global Investors 历史持仓 | Q1 2024 | 10.78K | $114.52K | 0.00% | 减持 |
| Fidelity Management & Research (FMR) 历史持仓 | Q2 2026 | 8.23K | $89.29K | 0.00% | 增持 |
| CPP Investments 历史持仓 | Q4 2025 | 4.60K | $76.31K | 0.00% | 增持 |
| PNC Financial Services 历史持仓 | Q2 2026 | 1.46K | $15.88K | 0.00% | 增持 |
| T. Rowe Price Associates 历史持仓 | Q2 2026 | 65.72K | $714 | 0.00% | 增持 |
| Amundi US 历史持仓 | Q1 2025 | 42 | $210 | 0.00% | 持有 |